Integro Theranostics
Clinical trials sponsored by Integro Theranostics, explained in plain language.
-
Glow-in-the-Dark dye could help surgeons spot lung cancer
Diagnosis CompletedThis early-stage trial tested a new fluorescent dye called LS301-IT in 24 people having lung cancer surgery. The dye is designed to attach to cancer cells and glow under a special light, helping surgeons see tumors more clearly. The main goals were to check safety and see how wel…
Phase: PHASE1 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden breast cancer
Diagnosis CompletedThis study tested a new imaging dye called LS301-IT in 22 women with early-stage breast cancer (DCIS or stage I-II) who were having a partial mastectomy. The dye is injected into a vein before surgery to make cancer cells glow, helping surgeons see and remove them more accurately…
Phase: PHASE1, PHASE2 • Sponsor: Integro Theranostics • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC